MEDIFAST Stock Today


USD 120.31  5.74  4.55%   

Market Performance
2 of 100
Odds Of Distress
Less than 27
MEDIFAST INC is trading at 120.31 as of the 2nd of December 2022, a -4.55 percent decrease since the beginning of the trading day. The stock's lowest day price was 119.81. MEDIFAST INC has about a 27 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for MEDIFAST INC are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 12th of December 2020 and ending today, the 2nd of December 2022. Click here to learn more.
Fiscal Year End
Business Domain
Household & Personal Products
IPO Date
31st of December 1993
Consumer Cyclical
Consumer Staples
Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company was founded in 1980 and is headquartered in Baltimore, Maryland. The company has 10.93 M outstanding shares of which 545.84 K shares are now shorted by investors with about 3.24 days to cover. More on MEDIFAST INC
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores

MEDIFAST INC Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. MEDIFAST INC's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding MEDIFAST INC or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
MEDIFAST INC has very high historical volatility over the last 90 days
Over 90.0% of the company shares are owned by institutional investors
On 8th of November 2022 MEDIFAST INC paid $ 1.64 per share dividend to its current shareholders
Latest headline from Medifast Named to the 2022 FORTUNE 100 Fastest-Growing Companies List - Yahoo Finance
ChairmanMichael MacDonald
Fama & French Classification
Average Analyst Recommendation
Analysts covering MEDIFAST INC report their recommendations after researching MEDIFAST INC's financial statements, talking to executives and customers, or listening in on MEDIFAST INC's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering MEDIFAST INC. The MEDIFAST consensus assessment is calculated by taking the average forecast from all of the analysts covering MEDIFAST INC.
Strong Buy2 Opinions
Piotroski F Score
Piotroski F-Score is a popular financial indicator that puts together nine criteria to evaluate the financial strength of MEDIFAST INC based on its profitability, leverage, liquidity, source of funds, and operating efficiency. It is an academic score (developed by Joseph Piotroski in 2002) to determine the current strength of MEDIFAST INC financial position. Scores of 8 and 9 are usually classified as strong value stocks, whereas scores of 2 or below are considered weak value stocks.
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares Diluted13.6 M11.8 M
Fairly Up
Slightly volatile
Weighted Average Shares13.5 M11.7 M
Fairly Up
Slightly volatile
Return on Average Assets52.4948.6443
Significantly Up
Slightly volatile
Net Cash Flow from Operations102 M94.5 M
Significantly Up
Slightly volatile
Current Liabilities183.2 M169.8 M
Significantly Up
Slightly volatile
Total Liabilities211.3 M195.9 M
Significantly Up
Slightly volatile
Gross Margin82.1873.8881
Moderately Up
Slightly volatile
Total Debt35.1 M32.5 M
Significantly Up
Slightly volatile
Asset Turnover3.674.5257
Significantly Down
Slightly volatile
Current Assets331.1 M306.9 M
Significantly Up
Slightly volatile
Total Assets429.8 M398.3 M
Significantly Up
Slightly volatile
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of MEDIFAST INC's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong BuyUndervalued
Financial Strength
MEDIFAST INC's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to MEDIFAST INC's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand MEDIFAST INC's financial leverage. It provides some insight into what part of MEDIFAST INC's total assets is financed by creditors.
Share Download
Share Download
By using current balance sheet information, investors can analyze the liability, assets, and equity on MEDIFAST INC's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how MEDIFAST INC deploys its capital and how much of that capital is borrowed.
MEDIFAST INC cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. MEDIFAST INC Debt to Equity Ratio is projected to slightly decrease based on the last few years of reporting. The past year's Debt to Equity Ratio was at 0.002843The company has a current ratio of 1.26, demonstrating that it may not be capable to disburse its financial commitments when the payables are due. Debt can assist MEDIFAST INC until it has trouble settling it off, either with new capital or with free cash flow. So, MEDIFAST INC's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like MEDIFAST INC sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for MEDIFAST to invest in growth at high rates of return. When we think about MEDIFAST INC's use of debt, we should always consider it together with cash and equity.

Operating Cash Flow

102.01 Million
MEDIFAST INC (MED) is traded on New York Stock Exchange in USA and employs 984 people. MEDIFAST INC is listed under Personal Products category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with total capitalization of 1.31 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate MEDIFAST INC's market, we take the total number of its shares issued and multiply it by MEDIFAST INC's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. MEDIFAST INC runs under Personal Products sector within Consumer Staples industry. The entity has 10.93 M outstanding shares of which 545.84 K shares are now shorted by investors with about 3.24 days to cover. MEDIFAST INC has about 104.18 M in cash with 94.55 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.57.
Check MEDIFAST INC Probability Of Bankruptcy
MEDIFAST INC holds a total of 10.93 Million outstanding shares. The majority of MEDIFAST INC outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in MEDIFAST INC to benefit from reduced commissions. Thereupon, institutional holders are subject to a different set of regulations than regular investors in MEDIFAST INC. Please pay attention to any change in the institutional holdings of MEDIFAST INC as this could imply that something significant has changed or about to change at the company. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.

Ownership Allocation (%)

Check MEDIFAST Ownership Details

MEDIFAST Stock Price Odds Analysis

What are MEDIFAST INC's target price odds to finish over the current price? Based on a normal probability distribution, the odds of MEDIFAST INC jumping above the current price in 90 days from now is about 21.36%. The MEDIFAST INC probability density function shows the probability of MEDIFAST INC stock to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon the stock has a beta coefficient of 1.3466. This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, MEDIFAST INC will likely underperform. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. MEDIFAST INC is significantly underperforming NYSE Composite.
  Odds Below 120.31HorizonTargetOdds Above 120.31
78.43%90 days
Based on a normal probability distribution, the odds of MEDIFAST INC to move above the current price in 90 days from now is about 21.36 (This MEDIFAST INC probability density function shows the probability of MEDIFAST Stock to fall within a particular range of prices over 90 days) .

MEDIFAST INC Historical Income Statement

MEDIFAST INC Income Statement is one of the three primary financial statements used for reporting MEDIFAST's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of MEDIFAST INC revenue and expense. MEDIFAST INC Income Statement primarily focuses on the company's revenues and expenses during a particular period.
MEDIFAST INC Consolidated Income is projected to increase significantly based on the last few years of reporting. The past year's Consolidated Income was at 164.03 Million. The current year Cost of Revenue is expected to grow to about 429.9 M, whereas Net Loss Income from Discontinued Operations is forecasted to decline to (453.5 K). View More Fundamentals

MEDIFAST Stock Against Markets

Picking the right benchmark for MEDIFAST INC stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in MEDIFAST INC stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for MEDIFAST INC is critical whether you are bullish or bearish towards MEDIFAST INC at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in MEDIFAST INC without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Fund Screener Now


Fund Screener

Find actively-traded funds from around the world traded on over 30 global exchanges
All  Next Launch Module

MEDIFAST INC Corporate Directors

MEDIFAST INC corporate directors refer to members of a MEDIFAST INC board of directors. The board of directors generally takes responsibility for the MEDIFAST INC's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of MEDIFAST INC's board members must vote for the resolution. The MEDIFAST INC board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Ming Xian - Independent DirectorProfile
Michael Hoer - Independent DirectorProfile
Jeffrey Brown - Lead Independent DirectorProfile
Glenn Welling - Independent DirectorProfile

Invested in MEDIFAST INC?

The danger of trading MEDIFAST INC is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of MEDIFAST INC is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than MEDIFAST INC. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile MEDIFAST INC is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Additionally, see Correlation Analysis. Note that the MEDIFAST INC information on this page should be used as a complementary analysis to other MEDIFAST INC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Complementary Tools for MEDIFAST Stock analysis

When running MEDIFAST INC price analysis, check to measure MEDIFAST INC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MEDIFAST INC is operating at the current time. Most of MEDIFAST INC's value examination focuses on studying past and present price action to predict the probability of MEDIFAST INC's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move MEDIFAST INC's price. Additionally, you may evaluate how the addition of MEDIFAST INC to your portfolios can decrease your overall portfolio volatility.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Global Correlations
Find global opportunities by holding instruments from different markets
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Equity Valuation
Check real value of public entities based on technical and fundamental data
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Is MEDIFAST INC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MEDIFAST INC. If investors know MEDIFAST will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MEDIFAST INC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
Market Capitalization
1.3 B
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of MEDIFAST INC is measured differently than its book value, which is the value of MEDIFAST that is recorded on the company's balance sheet. Investors also form their own opinion of MEDIFAST INC's value that differs from its market value or its book value, called intrinsic value, which is MEDIFAST INC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MEDIFAST INC's market value can be influenced by many factors that don't directly affect MEDIFAST INC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MEDIFAST INC's value and its price as these two are different measures arrived at by different means. Investors typically determine MEDIFAST INC value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MEDIFAST INC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.